跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Lesurix 40 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Lesurix 40
Approved
STANDARD
Lesurix 40
Stallion Laboratories Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
80480920556c66a5
Company
Stallion Laboratories Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
80480920556c66a5
Drug Approval Philippines Name
Lesurix 40
Product Name
Lesurix 40
Registration Number
DRP-10512-03
Brand Name
Lesurix 40
Generic Name
Febuxostat
Dosage Form
Film-Coated Tablet
Dosage Strength
40 mg
Manufacturer
Stallion Laboratories Pvt. Ltd.
Importer
Ambica International Corporation
Distributor
Ambicare Pharmaceuticals Inc.
Issuance Date
28 January 2022
Expiry Date
07 October 2026
Pharmacologic Category
Antigout
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
80480920556c66a5
Type
Standard
Back to Philippines FDA Approvals